GlassScriptPhysician profile
Joyce Corbeil Warwick
NPI 1265436844
$1,834.81
in general payments reported to CMS, 2019-2025
21 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $309 · 2023: $345 · 2024: $471 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672 · Education: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.94 |
| Education | $375.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $557.33 | 2021-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $283.02 | 2021-2024 | |
| Lilly USA, LLC | $132.47 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $126.59 | 2021 | |
| Allergan, INC. | $126.37 | 2021-2022 | |
| Abbvie INC. | $106.83 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $73.25 | 2023-2024 | Sotyktu |
| Orthofix Medical, INC. | $64.51 | 2025 | Cervical-Stim, Physio-Stim |
| Incyte Corporation | $54.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $43.47 | 2025 | |
| Stryker Corporation | $41.67 | 2025 | Clottriever Bold Catheter |
| Pfizer INC. | $36.44 | 2021-2022 | |
| Dermavant Sciences, INC. | $33.80 | 2023 | Vtama |
| Cerapedics INC. | $28.94 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $25.31 | 2025 | Mastergraft Matrix Ext |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $22.30 | 2021 | |
| Vericel Corporation | $21.39 | 2025 | |
| Biofrontera INC. | $18.95 | 2022 | |
| Galderma Laboratories, L.P. | $16.77 | 2024 | |
| Verrica Pharmaceuticals INC. | $14.68 | 2024 | Ycanth |
| Organon LLC | $6.32 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Warwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.